RESULTS: Researchers map microbiome in dogs with canine inflammatory disease
Morris Animal Foundation-funded researchers at the University of Melbourne, Australia, studied if specific gut bacteria can drive or exacerbate intestinal inflammation in dogs with inflammatory bowel disease or chronic enteropathy. Their findings could inform continuing studies on how the gut microbiome may be manipulated for novel treatments as well as inform the development of new diagnostics. Continue reading “Research Update MAF D18CA-045 Final: Understanding the Relationship between Intestinal Bacteria and Inflammatory Bowel Disease (IBD)”
Research Update CHF 02684-A Final: Evaluation of Serum Zonulin as a Non-invasive Biomarker and Therapeutic Target in Dogs with Chronic Canine Enteropathy
Canine chronic enteropathy (CE), is the most common cause of gastrointestinal (GI) disease in canine patients. The exact mechanisms leading to CE are unknown. Unfortunately, treatment for CE currently requires life-long management strategies (i.e. food elimination diets) which can be expensive and labor intensive for owners and/or require the use of medications which carry the risk for significant systemic side effects (i.e. steroids). Continue reading “Research Update CHF 02684-A Final: Evaluation of Serum Zonulin as a Non-invasive Biomarker and Therapeutic Target in Dogs with Chronic Canine Enteropathy”
Final Results on SmartPill Use for At-Home Diagnostics in GI Disorders
Final results for work from Dr. Pedro L Boscan, DVM, PhD of Colorado State University looking into the prospect of using the SmartPill device for at home diagnostics in canine gastrointestinal disorders.
Continue reading “Final Results on SmartPill Use for At-Home Diagnostics in GI Disorders”
